Immune to Cancer: The CRI Blog
-
Prostate Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Prostate Cancer Awareness Month, we look at new treatment combinations, new research, and how…
-
Advances in Immunotherapy for Prostate Cancer with Dr. Sumit Subudhi
For Prostate Cancer Awareness Month, CRI spoke with Dr. Sumit Subudhi about advances in immunotherapy for prostate…
-
Cancer Patients Gain Knowledge, Take Action
As a stage 4 metastatic breast cancer patient, Chawnté was eager to find immunotherapy clinical trial options.
-
CRI Scientific Leadership in Cancer and COVID-19
Members of the CRI Scientific Advisory Council are providing their immunology expertise and sharing lessons from cancer…
-
Stellar Science Solving Cancer and COVID-19
CRI Lloyd J. Old STARs are contributing to immunology work to combat COVID-19.
-
Medical Technology to Fight Cancer and COVID-19
CRI Technology Impact Award recipients are adapting technologies developed for cancer immunotherapies to understand and treat COVID-19….
-
Translating Cancer Immunotherapy Into COVID-19 Medicine
Investigators in CRI’s translational research program (CLIP) were quick to extend their cancer immunotherapy research into COVID-19…
-
Young Researchers Finding Answers to Cancer and COVID-19
Many CRI Irvington Postdoctoral Fellows pivoted their work, offered their expertise, volunteered their time, and have already…
-
Drew Griffin’s Immunotherapy Story: Advocating For LGBTQ+ Cancer Patients
CRI ImmunoAdvocate Drew Griffin discusses advocacy strategies for LGBTQ+ cancer patients and allies.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.